Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Faculty Members have conducted research related to the Combination Therapy of Sorafenib With Mesenchymal Stem Cells As a Novel Cancer Treatment Regimen in Xenograft Models of Hepatocellular Carcinoma
Mehdi Mohamadi
Mehdi Mohamadi

Assistant Professor of Medical Immunology

Department Immunology

School of Medicine

Tehran University of Medical Sciences

All Documents